Purvi Gada, MD
Medical Oncology & Hematology
Medical Degree, Topiwala National Medical College, Mumbai, India
Residency, State University of New York, Buffalo
Fellowship in Oncology, Hematology & Transplantation, University of Minnesota
Primary LocationChaska - Minnesota Oncology & Ridgeview Cancer & Infusion Center 110105 Pioneer Trail , Suite 302
Chaska, MN 55318
Phone: (952) 361-5800
Areas of Special Interest
- Breast cancer
- Colorectal Cancer
- Benign Hematology
- GU Cancers
Philosophy of Care
Dealing with cancer can be a difficult journey for patients and their families. As a hematologist and oncologist, I strive to travel this journey hand-in-hand with them, supporting their unique medical and personal needs and incorporating the latest evidence-based medicine.
Phase I Study of gemcitabine plus bortezomib in elderly patients with Solid tumors. Satya V Bommakanti, Purvi Gada, Mark Kirstein, Arkadiusz Z Dudek. Poster presentation at 100th Annual AACR Meeting, April 2009, Denver, Colorado (poster scored in top 3-4% of all abstracts presented at the meeting). Manuscript accepted in American Journal of Clinical Oncology.
Optimal NK cell expansion depends on accessory cell synergy between physiologic concentrations of IL-2 and IL-15, and UCB NK cell precursors expand better than adult NK cells. Purvi Gada, MBBS, Michelle Gleason, Valarie McCullar, Philip B McGlave, MD and Jeffrey S Miller, MD. Poster presentation in 2006 American Society of Hematology meeting.
Patterns of Bone Metastasis in advanced Renal Cell Carcinoma. A.C. Lynch, P.D. Gada, A.Z. Dudek, A.P. Ramani. University of Minnesota. Accepted for poster presentation at the 2006 World Congress of Endourology.
Prolonged remissions with autologous and allogenic stem cell transplantation for Burkitts Lymphoma: Long Term follow up at a Single Institution. Purvi Gada, M.B.B.S, Todd Defor, MS, Daniel J Weisdorf, MD, Jeffrey S Miller, MD, Paul Orchard, MD, Margaret L. MacMillan, M.D., Mukta Arora, MD, Marcie Tomblyn, MD, and Linda J Burns. Poster presentation in 2005 American Society of Hematology meeting.
Epratuzumab’s predominant antitumor activity in vitro/in vivo against Non-Hodgkin’s Lymphoma (NHL) is via Antibody-Dependent Cellular Cytotoxicity (ADCC). P. Gada, Francisco J. Hernandez-Ilizaliturri, E. Repasky, Myron S. Czuczman, Roswell Park Cancer Institute, Buffalo, NY. Poster presentation in the 44th 2002 American Society of Hematology meeting.
Enhancement in the biological activity of Rituximab when combined with Epratuzumab or Hu1D10 in a B-cell lymphoma severe combined immunodeficiency (SCID) mouse model. F.J. Hernandez-Ilizaliturri, P. Gada, E.A. Repasky and M.S. Czuczman; Roswell Park Cancer Institute, Buffalo, NY. Poster presentation in the 44th 2002 American Society of Hematology meeting.
Emerging Monoclonal Antibodies Against Non Hodgkin’s Lymphoma. F.J. Hernandez-Ilizaliturri, P. Gada, and M.S. Czuczman. Cancer Conference Highlights, March 2003, Vol. 7, No. 5.
- Medical Oncology
- Internal Medicine
- American Society of Clinical Oncology
- American Society of Hematology
I grew up in Mumbai, India, and have lived in Eden Prairie with my family for the last several years. In my free time, I like to read, cook, travel and spend time with my husband and son.